These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 26300315)
1. DAL-1/4.1B contributes to epithelial-mesenchymal transition via regulation of transforming growth factor-β in lung cancer cell lines. Yu F; Yang H; Zhang Z; Wang Z; Xiong J Mol Med Rep; 2015 Oct; 12(4):6072-8. PubMed ID: 26300315 [TBL] [Abstract][Full Text] [Related]
2. DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer. Chen X; Guan X; Zhang H; Xie X; Wang H; Long J; Cai T; Li S; Liu Z; Zhang Y J Exp Clin Cancer Res; 2015 Jan; 34(1):3. PubMed ID: 25609022 [TBL] [Abstract][Full Text] [Related]
3. Octamer-binding protein 4 affects the cell biology and phenotypic transition of lung cancer cells involving β-catenin/E-cadherin complex degradation. Chen ZS; Ling DJ; Zhang YD; Feng JX; Zhang XY; Shi TS Mol Med Rep; 2015 Mar; 11(3):1851-8. PubMed ID: 25420671 [TBL] [Abstract][Full Text] [Related]
4. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells. Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988 [TBL] [Abstract][Full Text] [Related]
5. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition. Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma. Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790 [TBL] [Abstract][Full Text] [Related]
7. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer. Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934 [TBL] [Abstract][Full Text] [Related]
8. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer. Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
10. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway. Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573 [TBL] [Abstract][Full Text] [Related]
11. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer. Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160 [TBL] [Abstract][Full Text] [Related]
12. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines. Terashima M; Tange S; Ishimura A; Suzuki T J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821 [TBL] [Abstract][Full Text] [Related]
13. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183 [TBL] [Abstract][Full Text] [Related]
14. Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors. Zhao L; Liu S; Che X; Hou K; Ma Y; Li C; Wen T; Fan Y; Hu X; Liu Y; Qu X Int J Mol Med; 2015 Sep; 36(3):645-52. PubMed ID: 26133118 [TBL] [Abstract][Full Text] [Related]
15. Angiogenin elevates the invasive potential of squamous cell lung carcinoma cells through epithelial‑mesenchymal transition. Xu L; Yan Y; Xue X; Li CG; Xu ZY; Chen HZ Oncol Rep; 2016 Nov; 36(5):2836-2842. PubMed ID: 27667357 [TBL] [Abstract][Full Text] [Related]
16. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition. Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845 [TBL] [Abstract][Full Text] [Related]
17. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer. Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090 [TBL] [Abstract][Full Text] [Related]
18. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma. Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989 [TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition. Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532 [TBL] [Abstract][Full Text] [Related]